Circulation Research, Vol 73, 846-856, Copyright © 1993 by American Heart Association

ARTICLES

Rapid turnover of the AMP-adenosine metabolic cycle in the guinea pig heart

K Kroll, UK Decking, K Dreikorn and J Schrader
Center for Bioengineering, University of Washington, Seattle.

The intracellular flux rate through adenosine kinase (adenosine-->AMP) in the well-oxygenated heart was investigated, and the relation of the AMP-adenosine metabolic cycle (AMP<-->adenosine) to transmethylation (S- adenosylhomocysteine [SAH]-->adenosine) and coronary flow was determined. Adenosine kinase was blocked in isolated guinea pig hearts by infusion of iodotubercidin in the presence of the adenosine deaminase blocker erythro-9-(2-hydroxy-3-nonyl)adenine (5 mumol/L). Iodotubercidin (1 nmol/L to 4 mumol/L) caused graded increases in venous effluent concentrations of adenosine, from 8 +/- 3 to 145 +/- 32 nmol/L (mean +/- SEM, n = 3), and in coronary flow, which increased to maximal levels. Flow increases were completely abolished by adenosine deaminase (5 to 10 U/mL). Interstitial adenosine concentrations, estimated using a mathematical model, increased from 22 nmol/L during control conditions to 420 nmol/L during maximal vasodilation. The possibility that iodotubercidin caused increased venous adenosine by interfering with myocardial energy metabolism was ruled out in separate 31P nuclear magnetic resonance experiments. To estimate total normoxic myocardial production of adenosine (AMP-->adenosine<--SAH), the time course of coronary venous adenosine release was measured during maximal inhibition of adenosine kinase with 30 mumol/L iodotubercidin. Adenosine release increased more than 15-fold over baseline, reaching a new steady-state value of 3.4 +/- 0.3 nmol.min-1 x g-1 (n = 5) after 4 minutes. In parallel experiments, the relative roles of AMP hydrolysis and transmethylation (SAH hydrolysis) were determined, using adenosine dialdehyde (10 mumol/L) to block SAH hydrolase. In these experiments, adenosine release increased to similar levels of 3.4 +/- 0.5 nmol.min-1 x g-1 (n = 6) during inhibition of adenosine deaminase and adenosine kinase. It is concluded that (1) maximal increases in coronary flow are elicited by increases in interstitial adenosine concentration to approximately 400 nmol/L, (2) more than 90% of the adenosine produced in the heart is normally rephosphorylated to AMP without escaping into the venous effluent, (3) AMP hydrolysis is the dominant pathway for cardiac adenosine production under normoxic conditions, and (4) the high rate of adenosine salvage is due to rapid turnover of a metabolic cycle between AMP and adenosine. Rapid cycling may serve to amplify the relative importance of AMP hydrolysis over transmethylation in controlling cytosolic adenosine concentrations.

This article has been cited by other articles:

				P. Meijer, W. J.G. Oyen, D. Dekker, P. H.H. van den Broek, C. W. Wouters, O. C. Boerman, G. J. Scheffer, P. Smits, and G. A. Rongen Rosuvastatin Increases Extracellular Adenosine Formation in Humans In Vivo: A New Perspective on Cardiovascular Protection Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 963 - 968. [Abstract] [Full Text] [PDF]

				P. P. Dzeja, P. Bast, D. Pucar, B. Wieringa, and A. Terzic Defective Metabolic Signaling in Adenylate Kinase AK1 Gene Knock-out Hearts Compromises Post-ischemic Coronary Reflow J. Biol. Chem., October 26, 2007; 282(43): 31366 - 31372. [Abstract] [Full Text] [PDF]

				T. H. Adair Growth regulation of the vascular system: an emerging role for adenosine Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R283 - R296. [Abstract] [Full Text] [PDF]

				U. Schlotzer-Schrehardt, M. Zenkel, U. Decking, D. Haubs, F. E. Kruse, A. Junemann, M. Coca-Prados, and G. O. H. Naumann Selective Upregulation of the A3 Adenosine Receptor in Eyes with Pseudoexfoliation Syndrome and Glaucoma Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2023 - 2034. [Abstract] [Full Text] [PDF]

				V. Randriamboavonjy, J. Schrader, R. Busse, and I. Fleming Insulin Induces the Release of Vasodilator Compounds From Platelets by a Nitric Oxide-G Kinase-VAMP-3-dependent Pathway J. Exp. Med., February 2, 2004; 199(3): 347 - 356. [Abstract] [Full Text] [PDF]

				J. P. Headrick, B. Hack, and K. J. Ashton Acute adenosinergic cardioprotection in ischemic-reperfused hearts Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818. [Abstract] [Full Text] [PDF]

				J. Peart, L. Willems, and J. P. Headrick Receptor and non-receptor-dependent mechanisms of cardioprotection with adenosine Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H519 - H527. [Abstract] [Full Text] [PDF]

				T. Pawelczyk, M. Podgorska, and M. Sakowicz The Effect of Insulin on Expression Level of Nucleoside Transporters in Diabetic Rats Mol. Pharmacol., January 1, 2003; 63(1): 81 - 88. [Abstract] [Full Text] [PDF]

				D. Pucar, P. Bast, R. J. Gumina, L. Lim, C. Drahl, N. Juranic, S. Macura, E. Janssen, B. Wieringa, A. Terzic, et al. Adenylate kinase AK1 knockout heart: energetics and functional performance under ischemia-reperfusion Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H776 - H782. [Abstract] [Full Text] [PDF]

				E. K. Jackson and R. K. Dubey Role of the extracellular cAMP-adenosine pathway in renal physiology Am J Physiol Renal Physiol, October 1, 2001; 281(4): F597 - F612. [Abstract] [Full Text] [PDF]

				J. Peart, G. Paul Matherne, R. J. Cerniway, and J. P. Headrick Cardioprotection with adenosine metabolism inhibitors in ischemic-reperfused mouse heart Cardiovasc Res, October 1, 2001; 52(1): 120 - 129. [Abstract] [Full Text] [PDF]

				T. Stumpe and J. Schrader Short-term hibernation in adult cardiomyocytes is PO2 dependent and Ca2+ mediated Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H42 - H50. [Abstract] [Full Text] [PDF]

				J.-W. Gu, B. R. Ito, A. Sartin, N. Frascogna, M. Moore, and T. H. Adair Inhibition of adenosine kinase induces expression of VEGF mRNA and protein in myocardial myoblasts Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2116 - H2123. [Abstract] [Full Text] [PDF]

				A. K. Hinschen, R. B. Rose'Meyer, and J. P. Headrick Age-related changes in A1-adenosine receptor-mediated bradycardia Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H789 - H795. [Abstract] [Full Text] [PDF]

				D. Kloor, W. Stumvoll, H. Schmid, J. Kömpf, A. Mack, and H. Osswald Localization of S-adenosylhomocysteine Hydrolase in the Rat Kidney J. Histochem. Cytochem., February 1, 2000; 48(2): 211 - 218. [Abstract] [Full Text]

				L. A Gustafson, C. J Zuurbier, J. E Bassett, J. P. F Barends, J. H.G.M van Beek, J. B Bassingthwaighte, and K. Kroll Increased hypoxic stress decreases AMP hydrolysis in rabbit heart Cardiovasc Res, November 1, 1999; 44(2): 333 - 343. [Abstract] [Full Text] [PDF]

				O. Culic, U. K. M. Decking, and J. Schrader Metabolic adaptation of endothelial cells to substrate deprivation Am J Physiol Cell Physiol, May 1, 1999; 276(5): C1061 - C1068. [Abstract] [Full Text] [PDF]

				A. Deussen, M. Stappert, S. Schafer, and M. Kelm Quantification of Extracellular and Intracellular Adenosine Production : Understanding the Transmembranous Concentration Gradient Circulation, April 20, 1999; 99(15): 2041 - 2047. [Abstract] [Full Text] [PDF]

				L. Belardinelli, J. C. Shryock, S. Snowdy, Y. Zhang, A. Monopoli, G. Lozza, E. Ongini, R. A. Olsson, and D. M. Dennis The A2A Adenosine Receptor Mediates Coronary Vasodilation J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1066 - 1073. [Abstract] [Full Text]

				L. A. Gustafson and K. Kroll Downregulation of 5'-nucleotidase in rabbit heart during coronary underperfusion Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H529 - H538. [Abstract] [Full Text] [PDF]

				S. A Manthei, C. M Reiling, and D. G.L Van Wylen Dual cardiac microdialysis to assess drug-induced changes in interstitial purine metabolites: adenosine deaminase inhibition versus adenosine kinase inhibition Cardiovasc Res, January 1, 1998; 37(1): 171 - 178. [Abstract] [Full Text] [PDF]

				M. Kelm, S. Schafer, R. Dahmann, B. Dolu, S. Perings, U. K.M Decking, J. Schrader, and B. E Strauer Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation Cardiovasc Res, November 1, 1997; 36(2): 184 - 194. [Abstract] [Full Text] [PDF]

				U. K. M. Decking, G. Schlieper, K. Kroll, and J. Schrader Hypoxia-Induced Inhibition of Adenosine Kinase Potentiates Cardiac Adenosine Release Circ. Res., August 19, 1997; 81(2): 154 - 164. [Abstract] [Full Text]

				D. M. Dennis, M.J. P. Raatikainen, J. R. Martens, and L. Belardinelli Modulation of Atrioventricular Nodal Function by Metabolic and Allosteric Regulators of Endogenous Adenosine in Guinea Pig Heart Circulation, November 15, 1996; 94(10): 2551 - 2559. [Abstract] [Full Text]

				R. K. Dubey, Z. Mi, D. G. Gillespie, and E. K. Jackson Cyclic AMP–Adenosine Pathway Inhibits Vascular Smooth Muscle Cell Growth Hypertension, November 1, 1996; 28(5): 765 - 771. [Abstract] [Full Text]

				D. W. Stepp, R. Van Bibber, K. Kroll, and E. O. Feigl Quantitative Relation Between Interstitial Adenosine Concentration and Coronary Blood Flow Circ. Res., September 1, 1996; 79(3): 601 - 610. [Abstract] [Full Text]

				T. Minamino, M. Kitakaze, K. Komamura, K. Node, H. Takeda, M. Inoue, M. Hori, and T. Kamada Activation of Protein Kinase C Increases Adenosine Production in the Hypoxic Canine Coronary Artery Through the Extracellular Pathway Arterioscler Thromb Vasc Biol, December 1, 1995; 15(12): 2298 - 2304. [Abstract] [Full Text]

				D. Pucar, E. Janssen, P. P. Dzeja, N. Juranic, S. Macura, B. Wieringa, and A. Terzic Compromised Energetics in the Adenylate Kinase AK1 Gene Knockout Heart under Metabolic Stress J. Biol. Chem., December 22, 2000; 275(52): 41424 - 41429. [Abstract] [Full Text] [PDF]